Pembrolizumab in Hepatocellular Carcinoma
NCT03419481
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
HCC
Interventions
DRUG:
pembrolizumab
Sponsor
CCTU